✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Mahavir Advanced Remedies Ltd.

MAHAREM 

Market Cap
₹171 Cr.
P/E
660.72

Mahavir Advanced Remedies Ltd.

  • IndoAmerican Advance
  • Krebs Biochem.&Inds
  • Bafna Pharma
FAQs on Mahavir Advanced Remedies Ltd. Shareprice

IndoAmerican Advance has given lower returns compared to its competitors.
IndoAmerican Advance has grown at ~0.0% over the last 7yrs while peers have grown at a median rate of 9.0%

There is insufficient historical data to gauge this.
Latest PE of IndoAmerican Advance is 660.72

View FAQ's On Business
Growth Table
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Balance Sheet
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Cash Flow
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Quarterly Results
  • Mahavir Advanced Remedies Ltd.
  • Krebs Biochem.&Inds
  • Bafna Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Mahavir Advanced Remedies Ltd. Financials

IndoAmerican Advance balance sheet is weak and might have solvency issues

The debt of IndoAmerican Advance is decreasing.
Latest debt of IndoAmerican Advance is -₹0.99 Crs as of Mar-14.
This is less than Mar-13 when it was -₹0.02 Crs.

Yes, profit is increasing.
The profit of IndoAmerican Advance is ₹0.14 Crs for Mar 2014, -₹0.15 Crs for Mar 2013 and -₹0.32 Crs for Mar 2012

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
IndoAmerican Advance latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech